Alejandro Lazo-Langner
Alejandro Lazo-Langner
Professor of Medicine, Western University
Verified email at - Homepage
Cited by
Cited by
Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism
TEPE Investigators
N Eng J Med 266, 1287-1297, 2012
Edoxaban versus Warfarin for the treatment of Symptomatic Venous Thromboembolism
THVTE investigators
New England Journal of Medicine 369 (15), 1406-1415, 2013
Apixaban to prevent venous thromboembolism in patients with cancer
M Carrier, K Abou-Nassar, R Mallick, V Tagalakis, S Shivakumar, ...
New England Journal of Medicine 380 (8), 711-719, 2019
Compression stockings to prevent post-thrombotic syndrome: a randomised placebo-controlled trial.
SOX trial investigators.
Lancet 383, 880-888, 2014
Thrombosis risk associated with COVID-19 infection. A scoping review
F Al-Ani, S Chehade, A Lazo-Langner
Thrombosis research 192, 152-160, 2020
Screening for occult cancer in unprovoked venous thromboembolism
M Carrier, A Lazo-Langner, S Shivakumar, V Tagalakis, R Zarychanski, ...
New England Journal of Medicine 373 (8), 697-704, 2015
Diagnosis of Pulmonary Embolism with d-Dimer Adjusted to Clinical Probability
C Kearon, K de Wit, S Parpia, S Schulman, M Afilalo, A Hirsch, ...
New England Journal of Medicine 381 (22), 2125-2134, 2019
The effect of low‐molecular‐weight heparin on cancer survival. A systematic review and meta‐analysis of randomized trials
A Lazo‐Langner, GD Goss, JN Spaans, MA Rodger
Journal of Thrombosis and Haemostasis 5 (4), 729-737, 2007
Development of a clinical prediction rule for risk stratification of recurrent venous thromboembolism in patients with cancer-associated venous thromboembolism
ML Louzada, M Carrier, A Lazo-Langner, V Dao, MJ Kovacs, TO Ramsay, ...
Circulation 126 (4), 448-454, 2012
Prothrombin complex concentrate for major bleeding on factor Xa inhibitors: a prospective cohort study
S Schulman, PL Gross, B Ritchie, S Nahirniak, Y Lin, L Lieberman, ...
Thrombosis and haemostasis 118 (05), 842-851, 2018
Management of cancer-associated anemia with erythropoiesis-stimulating agents: ASCO/ASH clinical practice guideline update
J Bohlius, K Bohlke, R Castelli, B Djulbegovic, MB Lustberg, M Martino, ...
Blood advances 3 (8), 1197-1210, 2019
A systematic review of treatment of drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in children
BR Del Pozzo-Magana, A Lazo-Langner, B Carleton, LI Castro-Pastrana, ...
Journal of Population Therapeutics and Clinical Pharmacology 18 (1), 2011
Fondaparinux for the treatment of suspected heparin-induced thrombocytopenia: a propensity score–matched study
M Kang, M Alahmadi, S Sawh, MJ Kovacs, A Lazo-Langner
Blood, The Journal of the American Society of Hematology 125 (6), 924-929, 2015
Guidance for the management of venous thrombosis in unusual sites
W Ageno, J Beyer-Westendorf, DA Garcia, A Lazo-Langner, RD McBane, ...
Journal of thrombosis and thrombolysis 41, 129-143, 2016
Prospective evaluation of a pharmacogenetics-guided warfarin loading and maintenance dose regimen for initiation of therapy
IY Gong, RG Tirona, UI Schwarz, N Crown, GK Dresser, S LaRue, ...
Blood, The Journal of the American Society of Hematology 118 (11), 3163-3171, 2011
Long‐term dalteparin in pregnancy not associated with a decrease in bone mineral density: substudy of a randomized controlled trial
MA Rodger, SR Kahn, A Cranney, A Hodsman, MJ Kovacs, AM Clement, ...
Journal of Thrombosis and Haemostasis 5 (8), 1600-1606, 2007
Clinical and genetic determinants of warfarin pharmacokinetics and pharmacodynamics during treatment initiation
IY Gong, UI Schwarz, N Crown, GK Dresser, A Lazo-Langner, GY Zou, ...
PloS one 6 (11), e27808, 2011
Venous thromboembolism in hospitalized critical and noncritical COVID-19 patients: a systematic review and meta-analysis
EM Mansory, S Srigunapalan, A Lazo-Langner
TH Open 5 (03), e286-e294, 2021
The effect of low molecular weight heparin on survival in cancer patients: an updated systematic review and meta‐analysis of randomized trials
D Sanford, A Naidu, N Alizadeh, A Lazo‐Langner
Journal of Thrombosis and Haemostasis 12 (7), 1076-1085, 2014
A prospective study of Rivaroxaban for central venous catheter associated upper extremity deep vein thrombosis in cancer patients (Catheter 2)
GA Davies, A Lazo-Langner, E Gandara, M Rodger, V Tagalakis, ...
Thrombosis research 162, 88-92, 2018
The system can't perform the operation now. Try again later.
Articles 1–20